Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $196.82 | 8 | 91.0% |
| Gift | $19.40 | 1 | 9.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $89.23 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $71.72 | 5 | $0 (2023) |
| Alcon Vision LLC | $23.71 | 1 | $0 (2024) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
| Allergan, Inc. | $12.16 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.71 | 1 | Alcon Vision LLC ($23.71) |
| 2023 | $19.13 | 1 | Novartis Pharmaceuticals Corporation ($19.13) |
| 2022 | $52.59 | 4 | Novartis Pharmaceuticals Corporation ($52.59) |
| 2020 | $31.56 | 2 | Carl Zeiss Meditec AG ($19.40) |
| 2018 | $89.23 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($89.23) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/01/2024 | Alcon Vision LLC | Precision 1 (Device) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Ophthalmology | ||||||
| 09/06/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Ophthalmology | ||||||
| 11/08/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/29/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/27/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/28/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/14/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/03/2020 | Carl Zeiss Meditec AG | None Specified (Medical Supply) | Gift | In-kind items and services | $19.40 | General |
| 11/15/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $89.23 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 997 | 1,099 | $155,268 | $67,436 |
| 2022 | 8 | 963 | 1,082 | $151,037 | $65,715 |
| 2021 | 8 | 935 | 1,005 | $137,049 | $62,188 |
| 2020 | 9 | 926 | 1,008 | $136,119 | $59,386 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 430 | 431 | $81,459 | $33,878 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 206 | $25,750 | $13,052 | 50.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 49 | 49 | $11,123 | $5,090 | 45.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 77 | 77 | $10,087 | $4,599 | 45.6% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 79 | 87 | $8,526 | $3,749 | 44.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 112 | 140 | $9,520 | $3,431 | 36.0% |
| 92134 | Imaging of retina | Office | 2023 | 91 | 96 | $6,528 | $2,640 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $2,275 | $997.00 | 43.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 442 | 445 | $84,105 | $35,859 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 196 | $24,004 | $12,388 | 51.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 40 | 40 | $9,080 | $3,738 | 41.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 57 | 58 | $7,598 | $3,425 | 45.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 118 | 144 | $9,792 | $3,412 | 34.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 67 | 75 | $7,350 | $3,281 | 44.6% |
| 92134 | Imaging of retina | Office | 2022 | 100 | 111 | $7,548 | $3,281 | 43.5% |
| 92250 | Photography of the retina | Office | 2022 | 12 | 13 | $1,560 | $331.44 | 21.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 388 | 388 | $73,332 | $31,661 | 43.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 142 | 187 | $20,383 | $12,209 | 59.9% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 48 | 48 | $10,896 | $4,443 | 40.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 78 | 78 | $10,218 | $4,305 | 42.1% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 110 | 118 | $8,024 | $3,357 | 41.8% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 88 | 97 | $6,596 | $2,477 | 37.6% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 51 | 55 | $5,390 | $2,388 | 44.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 30 | 34 | $2,210 | $1,348 | 61.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 316 | 318 | $60,102 | $26,433 | 44.0% |
About Dr. Anthony Zieja, OD
Dr. Anthony Zieja, OD is a Optometrist healthcare provider based in Gilford, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2009. The National Provider Identifier (NPI) number assigned to this provider is 1942432323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Zieja, OD has received a total of $216.22 in payments from pharmaceutical and medical device companies, with $23.71 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($196.82).
As a Medicare-enrolled provider, Zieja has provided services to 3,821 Medicare beneficiaries, totaling 4,194 services with total Medicare billing of $254,725. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Gilford, NH
- Active Since 08/18/2009
- Last Updated 10/06/2010
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1942432323
Products in Payments
- VYZULTA (Drug) $89.23
- XIIDRA (Drug) $71.72
- Precision 1 (Device) $23.71
- None Specified (Medical Supply) $19.40
- LUMIGAN (Drug) $12.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.